Cardiovascular risk factors

References

• Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med 1992; 326(21): 1406–16
   PubMed Web of Science ®Google Scholar
• Sleight P. Cardiovascular risk factors and the effects of intervention. Am Heart J 1991; 121(3 Pt2): 990–4
   PubMed Web of Science ®Google Scholar
• Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149(7): 1514–20
   PubMedGoogle Scholar
• Pool PE. The case for metabolic hypertension: is it time to restructure the hypertension paradigm? Prog Cardiovasc Dis 1993; 36(1): 1–38
   PubMed Web of Science ®Google Scholar
• Wenger NK, Speroff L, Packard B. Cardio vascular health and disease in women. N Engl J Med 1993; 329(4): 247–56
   PubMed Web of Science ®Google Scholar
• Yusuf S, Lessem J, Jha P, et al. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials. J Hypertens Suppl 1993; 11 (Suppl 4): S61–73
   PubMedGoogle Scholar
• Centers for Disease Control. Public health focus: physical activity and the prevention of coronary heart disease. MMWR 1993: 42(35): 669–72
   PubMedGoogle Scholar
• Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152(1): 56–64
   PubMedGoogle Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel II report. JAMA 1993; 269(23): 3015–23
   PubMed Web of Science ®Google Scholar
• Wong ND, Wilson PW, Kannel WB. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. Ann Intern Med 1991; 115(9): 687–93
   PubMed Web of Science ®Google Scholar
• Linn S, Fulwood R, Carroll M, et al. Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). Am J Public Health 1991; 81(8): 1038–43
   PubMed Web of Science ®Google Scholar
• Tennant M, McGeachie JK. Lipoprotein(a) and its role in occlusive vascular disease. Ann R Coll Surg Engl 1993; 75(l): 3–7
   PubMed Web of Science ®Google Scholar
• Rosengren A, Wilhelmsen L, Eriksson E, et al. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 1990; 301 (6763): 1248–51
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssö nen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86(3): 803–11
   PubMed Web of Science ®Google Scholar
• Nyboe J, Jensen G, Appleyard M, et al. Risk factors for acute myocardial infarction in Copenhagen. I: Hereditary, educational and socioeconomic factors. Copenhagen City Heart Study. Eur Heart J 1989; 10(10): 910–6
   PubMed Web of Science ®Google Scholar
• Elliott WJ, Karrison T. Increased all-cause and cardiac morbidity and mortality associated with the diagonal earlobe crease: a prospective cohort study. Am J Med 1991; 91 (3): 247–54
   PubMed Web of Science ®Google Scholar
• Grobbee DE, Rimm EB, Giovannucci E, et al. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 1990; 323(15): 1026–32
   PubMed Web of Science ®Google Scholar
• Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338(8765): 464–8
   PubMed Web of Science ®Google Scholar
• Suh I, Shaten BJ, Cutler JA, et al. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992; 116(11): 881–7
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328(20): l450–6
   Web of Science ®Google Scholar
• Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993: 328(20): 1444–9
   PubMed Web of Science ®Google Scholar
• Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA 1993; 269 (8): 998–1003 [Erratum, JAMA 1993; 269(19): 2508]
   PubMed Web of Science ®Google Scholar
• The Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a priori hypotheses of the trial. JAMA 1990; 263 (13): 1795–801 [Erratum, JAMA 1990; 263 (23): 3151]
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291(6488): 97–104
   PubMed Web of Science ®Google Scholar
• Cook DJ, Guyatt GH, Ryan G, et al. Should unpublished data be included in metaanalyses? Current convictions and controversies. JAMA 1993; 269(21): 2749–53
   PubMed Web of Science ®Google Scholar
• Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335(8693): 827–38
   PubMed Web of Science ®Google Scholar
• The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153(2): 154–83
   PubMed Web of Science ®Google Scholar
• Guidelines Sub-Committee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11(9): 905–18
   PubMed Web of Science ®Google Scholar
• Atkins D, Psaty BM, Koepsell TD, et al. Cholesterol reduction and the risk for stroke in men: a meta-analysis of randomized, controlled trials. Ann Intern Med 1993; 119(2): 136–45
   PubMed Web of Science ®Google Scholar
• Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993; 306 (6889): 1367–73 [Erratum, BMJ 1993: 306 (6893): 1648]
   PubMed Web of Science ®Google Scholar
• Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992; 305(6844): 15–9 [Erratum, BMJ 1992; 305(6852): 505]
   PubMed Web of Science ®Google Scholar